MintNeuro raises $5M to scale chips purpose-built for neural devices
Tech.eu Cate Lawrence
MintNeuro just raised $5M to push its brain-and-nerve chips into more devices. It’s betting purpose-built silicon can beat the slow, awkward route of custom chip design.
Based on reporting by Tech.eu, Cate Lawrence — read the original for the full story.
Summary, retelling and take written by AI under human oversight; images are AI-generated illustrations. How we work · Report an error
MintNeuro, a spinout from Imperial College London, has raised $5 million to scale the chips it is building for neural devices. The company makes specialised semiconductors for products that connect with the brain and nervous system, from implants to wearables.
The pitch is straightforward: as neurotechnology moves out of the lab and into clinical and commercial use, companies need something better than cobbling together generic parts or waiting through long custom chip cycles. MintNeuro wants to be the chip platform built specifically for that job.
The round was led by Odyssey Ventures, with support from 33East, JSK Investments and Alumni Ventures, plus returning capital from Empirical Ventures, Jumpspace Ventures and early backers. MintNeuro says it has already delivered working silicon and hit integration milestones with partners including Motif Neurotech and Amber Therapeutics.
That matters because the company is not starting from a blank page. Earlier this year it announced a partnership and multi-year commercial chip supply deal with Motif Neurotech, which is developing a minimally invasive neurostimulator aimed first at treatment-resistant depression. Other neural device companies are also evaluating or integrating MintNeuro’s technology.
Its modular platform handles neural sensing, signal processing and stimulation: reading nerve signals, interpreting them and sending precise electrical pulses back. MintNeuro says that setup can make devices smaller, lower-power and more tightly closed-loop. The new money will go into engineering and commercial hiring, product launches, customer support and a stronger US presence alongside its UK and European base.
My take — AI-written commentary, not fact-checked reporting
This is the kind of unglamorous infrastructure bet neurotech keeps needing and rarely gets enough of. The flashy part is the brain interface; the boring part is the chip that has to make the whole thing practical. That’s where the value is, and also where the industry keeps tripping over its own ambition.
Read more about this at: Tech.eu
